Post-Operative Accelerated-Hypofractionated Chemoradiation With Volumetric Modulated Arc Therapy and Simultaneous Integrated Boost in Glioblastoma: A Phase I Study (ISIDE-BT-2)

BackgroundGlioblastoma Multiforme (GBM) is the most common primary brain cancer and one of the most lethal tumors. Theoretically, modern radiotherapy (RT) techniques allow dose-escalation due to the reduced irradiation of healthy tissues. This study aimed to define the adjuvant maximum tolerated dos...

Descripció completa

Dades bibliogràfiques

Autors principals:	Marica Ferro, Milena Ferro, Gabriella Macchia, Savino Cilla, Milly Buwenge, Alessia Re, Carmela Romano, Mariangela Boccardi, Vincenzo Picardi, Silvia Cammelli, Eleonora Cucci, Samantha Mignogna, Liberato Di Lullo, Vincenzo Valentini, Alessio Giuseppe Morganti, Francesco Deodato
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2021-02-01
Col·lecció:	Frontiers in Oncology
Matèries:	glioblastoma multiforme volumetric modulated arc therapy simultaneous integrated boost adjuvant treatment temozolomide
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fonc.2020.626400/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!